RaySearch Laboratories AB (publ) announced that The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), in the USA, has placed an order for the treatment planning system RayStation®. Revenue from the order will be recognized in the fourth quarter, 2022. The department of Radiation Oncology will utilize a Varian ProBeam® 360 for proton therapy, and also has several Varian linear accelerators in service. The OSUCCC - James will use the latest RayStation technologies, such as deep learning segmentation, image deformation, adaptive planning, multi-criteria optimization, and fallback planning, which allows for contingency planning and comparison of modalities to help clinicians select the most appropriate treatment technique.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
141 SEK | +1.29% |
|
+4.72% | +57.25% |
07-01 | RaySearch Releases RayStation 2024B | CI |
05-30 | RaySearch Laboratories AB Releases RayCare 2024A | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+57.25% | 451M | |
-3.52% | 30.03B | |
+40.70% | 9.47B | |
+31.92% | 4.33B | |
-41.69% | 2.21B | |
-6.10% | 1.66B | |
-40.78% | 1.01B | |
-4.87% | 852M | |
-51.15% | 681M | |
-32.00% | 604M |
- Stock Market
- Equities
- RAY B Stock
- News RaySearch Laboratories AB
- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Select RayStation for Proton Planning